ZHUANG Zhigang, MD, PhD., Chief Physician and Administrative Director of the Breast Surgery Department at the Obstetrics and Gynecology Hospital affiliated with Tongji University.

Professional Experience:
Since 2010, Dr. ZHUANG has visited UCLA in the United States, AKH in Austria, and the Mayo Clinic in the United States for academic exchanges and training. He serves as an editorial board member for the Journal of Tongji University. Dr. ZHUANG has led multiple scientific research projects, including the Shanghai Natural Science Foundation, Shanghai Municipal Commission of Health and Family Planning Medical Guidance Projects, and Shanghai Municipal Health Bureau projects. He has also participated in key medical field projects of the Shanghai Municipal Commission of Science and Technology. Dr. ZHUANG is the editor of Common Breast Diseases Consultation and Breast Cancer Consultation, and a contributing author to New Challenges in Communication with Cancer Patients. He has published over 60 papers, including more than 20 SCI-indexed articles, with more than 10 as the first or corresponding author.

Specialties:
• Diagnosis and treatment of benign tumors, breast lumps, nipple discharge, and related breast diseases；
• Diagnosis and treatment of breast cancer and soft tissue tumors；
• Oncoplastic surgery for malignant breast tumors.

Academic Appointments:
• Member of the American Society of Clinical Oncology (ASCO)
• Standing Committee Member of the Tumor Marker Professional Committee of the Chinese Anti-Cancer Association
• Standing Committee Member of the Breast Disease Professional Committee of the China Maternal and Child Health Association
• Member of the Oncoplastic Surgery Branch of the China International Exchange and Promotive Association for Medical and Health Care
• Chairman of the Breast Disease Prevention and Treatment Professional Committee of the Shanghai Maternal and Child Health Association
• Vice Chairman of the Thyroid and Breast Surgery Professional Committee of the Shanghai Association of Integrative Medicine
• Vice Chairman of the Breast Health and Popular Science Committee of the Health Science Branch of the Shanghai Association for Science and Technology
• Standing Committee Member of the Breast Cancer Professional Committee of the Shanghai Anti-Cancer Association
• Standing Committee Member of the Breast Disease Professional Committee of the Shanghai Association of Integrative Medicine

Dr. Xue Guanhua is currently a multi-site practicing physician at Jiahui Health, holds a Ph.D. in Surgery from the Vascular Surgery Department of Renji Hospital affiliated with Shanghai Jiao Tong University School of Medicine, and is a Chief Physician and Doctoral Supervisor. He has been awarded the "China University Students Jianhao Scholarship," "National Merit Student," and several awards in Shanghai. From June to September 2007, he was funded by the "Hundred Talents Program" of the School of Medicine at Shanghai Jiao Tong University to study at the Vascular Intervention Center of Leipzig University in Germany. In July 2015, he was invited to the University of Southern California and Stanford University Hospital for academic exchange. He has published 70 papers in core domestic and international journals, including 23 SCI papers (IF=141.90), with 7 papers scoring over 10. He has led two general projects of the National Natural Science Foundation of China, two projects of the Shanghai Municipal Science and Technology Commission (provincial and ministerial level), one "Industry-University-Research" special fund project of the Shanghai Pudong New Area Science and Technology Development Fund, and one Shanghai Medical-Engineering Cross-Innovation Project. He has participated in the compilation and translation of 5 monographs and is the chief editor of one, "Advances in the Diagnosis and Treatment of Aortoiliac Surgical Diseases." He has participated in the completion of three global multicenter clinical drug studies and holds 15 invention (utility) patents.

Social Appointments:
Chairman of the Aortoiliac Surgery Expert Committee of the Peripheral Vascular Diseases Committee of the Chinese Microcirculation Society
Vice Chairman of the Aortoiliac Surgery Group of the Vascular Surgery Branch of the China International Exchange and Promotive Association for Medical and Health Care
Vice Chairman of the Chinese Vascular Trauma Expert Committee of the International Union of Angiology (IUA)
Member of the International Society for Vascular Surgery (ISVS)
Vice President of the Translational Medicine Industry Branch of the National Health Industry Enterprise Management Association
Vice Chairman of the First Vascular Branch of the Overseas Returned Scholars Association of the Medical Doctor Association
Deputy Secretary-General of the Vascular Devices Branch of the China Medical Device Industry Association
Vice Chairman of the Vascular Surgery Committee of the Shanghai Medical Association
Honorary Chairman of the Vascular Surgery Committee of the Shanxi Health Management Association
Editorial Board Member of the "Chinese Journal of Vascular Surgery," "Chinese Journal of Vascular Surgery (Electronic Edition)," "Journal of Vascular and Endovascular Surgery," and "Journal of Vascular and Endovascular Surgery."

Dr. LYU Jingrong serves as the multi-site practice physician at Jiahui Health. He is titled as Chief Physician and Master’s Supervisor with a doctor degree in Medicine. He is currently the Teaching Director of the Otolaryngology Head and Neck Surgery Department at Shanghai Xinhua Hospital, a national key clinical specialty, and leads the pediatric laryngology and head and neck subspecialty. With extensive experience in clinical work and basic research in otolaryngology, he has published over twenty papers and reviews in authoritative international and domestic journals. He was a visiting scholar at the Massachusetts Eye and Ear Infirmary, Harvard University, USA. His current research focuses on congenital hearing disorders in children and vestibular medicine.

Dr.LYU holds several committee memberships, including:
• Youth Committee Member of the Head and Neck Group, Chinese Anti-Cancer Association Rehabilitation Society
• Youth Committee Member of the Pediatric Otolaryngology Group, Chinese Medical Doctor Association
• Youth Committee Member of the Head and Neck Tumor Expert Committee, Chinese Anti-Cancer Association
• Youth Committee Member of the Academic Guidance Committee, Head and Neck Group, Chinese Anti-Cancer Association Rehabilitation Society
• Youth Committee Member of the Pediatric Otolaryngology Youth Professional Committee, Chinese Medical Doctor Association
• Vice Chairman of the 19th Laryngology Group, 18th Shanghai Medical Association Otolaryngology Head and Neck Surgery Branch
• Member of the 18th Shanghai Otolaryngology Head and Neck Surgery Laryngology Group
• Member of the Head and Neck Surgery Group, 6th Otolaryngology Professional Committee, Shanghai Association of Integrative Medicine

Dr. LYU is proficient in diagnosing and treating various otolaryngological diseases. His main research and clinical focuses include:
1. Minimally invasive surgical treatment for pediatric adenoid hypertrophy, tonsillar hypertrophy, and secretory otitis media.
2. Surgical treatment of congenital neck masses in children, such as thyroglossal duct cysts, branchial cleft cysts, and fistulas.
3. Surgical treatment of neck masses, submandibular gland, and parotid gland tumors in both children and adults, as well as various benign and malignant laryngeal tumors.
4. Minimally invasive surgeries for sinusitis, nasal polyps, and nasal tumors.

His primary scientific research areas include the pathogenesis of pediatric adenoid hypertrophy and its developmental impacts, the pathogenesis of pediatric neck tumors, screening for congenital hearing disorders in children, and medical research related to vestibular development. 

Dr. GE Di, Deputy Director of the Thoracic Surgery Department and Director of the Lung Cancer Center at Zhongshan Hospital, affiliated with Fudan University, doctoral supervisor.

Specialties:
• Differential diagnosis of small pulmonary nodules and management of locally advanced lung cancer;
• Minimally invasive surgery and conventional thoracotomy for lung, esophageal, and mediastinal tumors;
• Carinal surgery, sleeve lobectomy, esophageal resection with colonic interposition, completion pneumonectomy, and radical esophagostomy after partial gastrectomy;

Academic appointment
• Vice Chairman of the Thoracic Surgery Branch of the Shanghai Medical Association;
• Member of the Society of Thoracic Surgeons (STS), USA;
• Fellow of the American College of Chest Physicians (FCCP);
• Vice Chairman of the Thoracic Surgery Branch of the Shanghai Association of Integrative Medicine;
• Member of the Lung Cancer Study Group of the Thoracic and Cardiovascular Surgery Branch of the Chinese Medical Association;
• Vice Chairman of the Lung Cancer Study Group of the Shanghai Anti-Cancer Association;
• Vice Chairman of the Thoracic Surgery Committee of the Chinese Medical Education Association;
• Standing Committee Member of the Thoracic Surgery Professional Committee of the China Medical Foundation;

Specialties: Lower extremity venous diseases, varicose veins, venous ulcers (chronic leg ulcers), vasculitis, venous thrombosis, iliac vein stenosis, and compression.

Introduction:
Dr. TIAN Wen is currently a multi-site practicing physician at Jiahui Health, specializing in the minimally invasive daytime treatment of varicose veins. Trained under the renowned vascular surgery expert Professor Jing Zaiping, Dr. Tian has 10 years of experience in the varicose veins specialty group at Shanghai Changhai Hospital. He is one of the earliest doctors in China to perform daytime local anesthesia surgeries for varicose veins. Currently, he is a member of the venous group in the vascular surgery department at Shanghai First People's Hospital, having completed over 10,000 varicose vein surgeries. His expertise ranges from cosmetic treatments for minor "spider veins" to severe venous ulcers, and from congenital venous malformations to recurrent varicose veins, with a comprehensive treatment system and extensive experience. His primary focus is on the diagnosis and treatment of lower extremity venous reflux diseases and their complications. Dr. Tian has led one Shanghai Municipal Science and Technology Commission fund project and one hospital-level fund project, participated in four National Natural Science Foundation projects, co-authored several academic works including Endovascular Surgery and Devices, and published two SCI papers and two core journal papers in China. He holds a domestic utility model patent and has experience in medical-engineering collaboration, serving as the chief medical consultant for several medical device innovation companies. Dr. Tian has also participated in academic exchanges at Lukas Hospital in Düsseldorf, Germany, the Medical School of the University of Bonn, and the vascular surgery department at Martha Maria Hospital in Nuremberg, and has trained foreign doctors from five countries.

Professional Affiliations:
• Member and Secretary of the Venous Reflux Disease Expert Committee, Chinese Medical Doctor Association
• Member of the Venous Disease Professional Committee, China Senior Citizens Health Association
• Member of the Doctor Group Branch, Chinese Non-Governmental Medical Institutions Association
• Council Member of the Intelligent Diagnosis and Treatment Branch of Chinese and Western Surgery, China Information Association for Traditional Chinese Medicine
• Member of the Vascular Surgery Branch, Shanghai Medical Association

Dr. TAO Chen, Chief Physician, Deputy Director of the Department of Ophthalmology, Renji Hospital, Shanghai Jiao Tong University School of Medicine. Dr.Tao studied at the University of British Columbia and its affiliated Hospital as a visiting scholar in 2005.

Specialties:
• The diagnosis and treatment of common ophthalmic diseases such as glaucoma, chronic dacryocystitis, dry eye, etc.
• Individualized treatment of various types of strabismus and amblyopia;
• Life-cycle refractive error prevention and correction, such as adolescent myopia prevention and control, adult ICL myopia correction, refractive cataract surgery in the elderly;
• Differential diagnosis of diplopia caused by diseases such as diabetes, hypertension, and infection;

Academic appointment
• Member of oblique amblyopia Group, Ophthalmology Society of Shanghai Medical Association;
• Deputy Director of Ophthalmology Group, Laser Society of Shanghai Medical Association;
• Member of Shanghai Optometry Society;
• Member of Ophthalmology Professional Committee of Chinese Medical Equipment Association;

Associate Chief Physician, part-time physician at Jiahui Health Plastic Surgery Department and Associate Chief Physician of Plastic Surgery at Renji Hospital, Shanghai Jiaotong University School of Medicine.

Dr. FU has long been involved in the medical teaching and research work of plastic surgery department, with nearly 30 years of clinical experience and unique insights in body surface tumors, especially facial surgery scar minimization, and assisted other departments such as General Surgery, Breast Surgery, Brain Surgery, Urology and other departments in the repair of wounds after resection of huge tumors, and has long been leading and teaching postgraduates, trainees, and residents of Plastic and Reconstructive Surgery, trainee doctors. She specializes in cosmetic surgery such as body tumor resection wound repair, gynecological plastic surgery, hair transplantation, scar treatment, hand trauma, blepharoplasty eye bags axillary minimally invasive surgery.

Dr. FU was appointed as the eighth and ninth member of Shanghai Medical Association Plastic and Reconstructive Surgery Specialized Branch in 2011 and 2014, the first and second member of Plastic and Reconstructive Surgery Department of Shanghai Medical Doctors Association in 2014 and 2018, and a member of the Shanghai Working Committee of Chinese Physicians Association of Aesthetics and Plastic Surgery Doctors Branch in 2010-2013, and has been recognized as a member of the International Society for Plastic Reconstructive and Aesthetic Surgery, IPRAS. Dr. FU is an inspector with more than 10 years of experience in the Renji group of the Municipal Medical Cosmetology Quality Control Center, and has participated in the city's medical cosmetology quality control inspections twice a year for 15 consecutive years.

Dr. FU participated in writing the chapter of hair transplantation and microsurgical techniques for the Shanghai Plastic Surgery Specialized Training Textbook and the accompanying test questions, and participated in the laboratory and clinical research of the Science and Technology Commission's project, “Experimental Research on the Mechanisms of FAK in Keloid Scar Proliferation and its Gene Therapy”, and authored a total of articles on “Extra-mammary Paget's Disease”, "Expression and Significance of Adhesion Plaque Kinase in Proliferative Keloid Scar Fibroblasts “, ”Study on the function of focal adhensive kinase and integrinα1 in hypertrophic scar fibroblasts" and 5 other papers published in national level professional journals.

Clinical experience
Dr. LI Tao currently serves as an Andrologist at the Fertility and Reproductive Medicine Center of Jiahui Hospital. He holds a Ph.D. degree. Prior to joining Jiahui Hospital, Dr. Li was affiliated with the Obstetrics and Gynecology Hospital of Fudan University (Red House Hospital), where he developed robust theoretical expertise and accumulated over 30 years of clinical experience in male reproductive and urological medicine. He obtained both his M.D. and Ph.D. degrees from Shanghai Jiao Tong University School of Medicine. During his graduate studies, he received mentorship from renowned urology and male reproductive medicine specialists at Renji Hospital, Shanghai Jiao Tong University, including Professors Wang Yixin and Huang Yiran, with a research focus on reproductive biology and urology. Following graduation, Dr. Li pursued clinical and research positions at Shanghai Sixth People’s Hospital and Tongji Hospital. Between 2009 and 2011, he completed postdoctoral research in urology at Ruijin Hospital, Shanghai.

Specializes
Specialize in the treatment of male infertility, including azoospermia, oligospermia, asthenospermia, and teratozoospermia. Proficient in microsurgical procedures pertinent to reproductive andrology, such as vasoepididymostomy (VE), vasovasostomy (VV), varicocelectomy (microsurgical approach), and microdissection testicular sperm extraction (m-TESE); also adept at transurethral aspiration of testicular sperm (TESA) and percutaneous epididymal sperm aspiration (PESA). Skilled in performing endoscopic urogenital surgeries, such as ureteroscopy, cystoscopy, and seminal vesiculoscopy. Possess a robust clinical and theoretical foundation in managing male sexual dysfunction, including erectile dysfunction (ED) and premature ejaculation (PE), as well as in the treatment of urogenital infections, particularly chronic prostatitis.

Research Projets and Awards
As the first author or corresponding author, Dr.Li has published more than ten SCI - indexed articles.He conducted postdoctoral research work at Shanghai Ruijin Hospital, and the relevant research results were published in the internationally renowned urology journal---the Journal of Urology.

Other Awards
Recipient of the Third Prize for Shanghai Science and Technology Progress and the Second Prize for Shanghai Medical Science and Technology.
Co-author of "Andrology Therapeutics" (Science and Technology Documentation Press, Beijing, 2002) and "Surgical Oncology of the Genitourinary System" (People's Medical Publishing House, Beijing, 2011).
Independent fulfillment of a General Project (Category A) under the 2010 Postdoctoral Research Sponsorship Program of Shanghai.